Biotechnology
ARTBIO is a clinical-stage biotech company focused on radiopharmaceutical development. The company develops investigational radiopharmaceutical programs with a primary focus on oncology applications. ARTBIO progresses its pipeline from pre-IND through Phase 3 clinical trials, working across research, development, and regulatory functions to bring novel radiopharmaceuticals toward commercialization.
Beta · Sourced from candidate reports
Be the first to share your experience with ARTBIO.
Your reply helps other candidates know what to expect.
